Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer

Thomas J. Herzog, Sandro Pignata, Sharad Ghamande, Maria-Jesús Rubio, Keiichi Fujiwara, Christof Vulsteke, Deborah K. Armstrong, Jalid Sehouli, Robert L. Coleman, Hani Gabra, Giovanni Scambia, Bradley J. Monk, José Ángel Arranz, Kimio Ushijima, Rabbie K. Hanna, Claudio Zamagni, Robert M. Wenham, Antionio González-Martín, Brian M. Slomovitz, Yan Jia, Lisa Ramsay, Krishnansu S. Tewari, Susan C. Weil, Ignace Vergote